RS54074B1 - METHODS AND COMPOSITIONS CONTAINING SUPRAMOLECULAR STRUCTURES - Google Patents

METHODS AND COMPOSITIONS CONTAINING SUPRAMOLECULAR STRUCTURES

Info

Publication number
RS54074B1
RS54074B1 RS20150393A RSP20150393A RS54074B1 RS 54074 B1 RS54074 B1 RS 54074B1 RS 20150393 A RS20150393 A RS 20150393A RS P20150393 A RSP20150393 A RS P20150393A RS 54074 B1 RS54074 B1 RS 54074B1
Authority
RS
Serbia
Prior art keywords
seq
antigenic peptide
antibody
peptide
antigenic
Prior art date
Application number
RS20150393A
Other languages
English (en)
Serbian (sr)
Inventor
Yves NICOLAU CLAUDE
Ruth Greferath
David Hickman
Original Assignee
Ac Immune Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/783,975 external-priority patent/US20040242845A1/en
Priority claimed from US10/958,211 external-priority patent/US8663650B2/en
Application filed by Ac Immune Sa filed Critical Ac Immune Sa
Publication of RS54074B1 publication Critical patent/RS54074B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RS20150393A 2004-02-20 2005-02-22 METHODS AND COMPOSITIONS CONTAINING SUPRAMOLECULAR STRUCTURES RS54074B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/783,975 US20040242845A1 (en) 2003-02-21 2004-02-20 Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
US10/958,211 US8663650B2 (en) 2003-02-21 2004-10-04 Methods and compositions comprising supramolecular constructs

Publications (1)

Publication Number Publication Date
RS54074B1 true RS54074B1 (en) 2015-10-30

Family

ID=46395388

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150393A RS54074B1 (en) 2004-02-20 2005-02-22 METHODS AND COMPOSITIONS CONTAINING SUPRAMOLECULAR STRUCTURES

Country Status (11)

Country Link
JP (1) JP4934433B2 (ru)
KR (1) KR101277004B1 (ru)
CY (1) CY1116316T1 (ru)
DK (1) DK2465533T3 (ru)
ES (2) ES2539262T3 (ru)
HK (2) HK1130698A1 (ru)
HR (1) HRP20150612T1 (ru)
HU (1) HUE025186T2 (ru)
PT (1) PT2465533E (ru)
RS (1) RS54074B1 (ru)
SI (1) SI2465533T1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2885398T3 (es) * 2009-03-18 2021-12-13 Ac Immune Sa Método para uso terapéutico
WO2012055933A1 (en) 2010-10-26 2012-05-03 Ac Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187335B1 (en) * 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
AU2600499A (en) * 1998-02-13 1999-08-30 Arch Development Corporation Methods and compositions comprising the use of blocked b-amyloid peptide
MXPA02006215A (es) * 1999-12-22 2003-10-15 Nektar Therapeutics Al Corp Metodo para preparar esteres de 1-benzotriazolil carbonato de poli(etilenglicol).

Also Published As

Publication number Publication date
HK1172260A1 (en) 2013-04-19
KR101277004B1 (ko) 2013-06-24
HUE025186T2 (en) 2016-02-29
HK1130698A1 (en) 2010-01-08
SI2465533T1 (sl) 2015-07-31
ES2539262T3 (es) 2015-06-29
ES2385226T3 (es) 2012-07-19
JP4934433B2 (ja) 2012-05-16
KR20120097546A (ko) 2012-09-04
PT2465533E (pt) 2015-06-24
HRP20150612T1 (hr) 2015-07-03
CY1116316T1 (el) 2017-02-08
JP2007527870A (ja) 2007-10-04
DK2465533T3 (en) 2015-04-20
ES2385226T9 (es) 2013-10-10

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
RS51635B (sr) Antitela koja blokiraju cripto i njihova upotreba
HRP20040712B1 (hr) Anti-amiloidna beta antitijela i njihova uporaba
CY1106876T1 (el) Συσκευασια και μεθοδος ανιχνευσεως της πρωτεϊνης esm-1
RS52769B (sr) Kompozicije i postupci za povećanje mineralizacije kostiju
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
US7485321B2 (en) Peyer's patch and/or M-cell targeting ligands
UY28641A1 (es) Anticuerpos
FR2889416B1 (fr) Composition de proteines de pois
EA200870538A1 (ru) Лиофилизированные композиции анти-egfr антител
HUP0004639A2 (hu) Chlamydia fehérje, génszekvencia és ezek alkalmazása
RS54056B1 (en) ANTI-CD38 HUMAN ANTIBODIES AND THEIR USES
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
DE60043620D1 (de) Mage-a1 peptide die von klasse ii hla molekule presentiert werden
JP2002505841A5 (ru)
RS54074B1 (en) METHODS AND COMPOSITIONS CONTAINING SUPRAMOLECULAR STRUCTURES
RS50831B (sr) Izolovano antitelo ili fragment antitela koji se specifično vezuju za rg1 polipeptid
AR066311A1 (es) Moleculas de anticuerpos anti proteina hsp90 fungica y acidos nucleicos que los codifican
DE60127113D1 (de) Gd3 mimetische peptide
FR2815634B1 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
WO2006038101A3 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
WO2003089472A3 (en) Anti-nls scfv and peptides and uses thereof in nuclear import inhibition